VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Stock Comparison
CSL Limited vs Thales S.A.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
CSL Limited
CSL · ASX
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Thales S.A.
HO · Euronext Paris
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: CSL Limited leads (77 / 100 vs 73 / 100 for Thales S.A.).
- Segment focus: CSL Limited has 3 segments (71.7% in CSL Behring); Thales S.A. has 3 segments (53.3% in Defence).
- Moat breadth: CSL Limited has 7 moat types across 3 domains; Thales S.A. has 8 across 3.
Primary market context
CSL Limited
CSL Behring
Plasma-derived therapies (immunoglobulins, albumin, coagulation factors) plus recombinant and gene therapies for rare and serious diseases
Global
Hospitals, specialty pharmacies, physicians; payers and national health systems
Vertically integrated biopharma (plasma collection -> fractionation/manufacturing -> commercial distribution)
71.7%
Thales S.A.
Defence
Defense electronics, secure communications, and mission systems
Global
Government / defence ministries, armed forces, security forces
Prime contractor and system integrator; OEM of defence electronics
53.3%
Side-by-side metrics
Moat coverage
Shared moat types
CSL Limited strengths
Thales S.A. strengths
Segment mix
CSL Limited segments
Full profile >CSL Behring
Oligopoly
CSL Seqirus
Oligopoly
CSL Vifor
Oligopoly
Thales S.A. segments
Full profile >Defence
Oligopoly
Aerospace
Oligopoly
Cyber & Digital
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listLooking for expansion-stage stocks?
Proven models entering the expansion stage with unit economics that work.
View expansion-stage stocksCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.